November 21, 2019 PK Submit generates PK CDISC domains automatically, allowing sponsors to file regulatory submissions faster, while also improving data organization and compliance
This webinar addressed some of the challenges associated with pediatric drug development and the advantages (and limitations) that pediatric population PK modeling can provide.
Certara uses a unique set of disciplines and technologies to address the challenges that infectious disease drug programs face.
Aligned with newly issued FDA Draft Guidance, Phoenix supports electronic data, methods and results audit, traceability and communication requirements.
This webinar showed how to use a time correction factor to establish a meaningful IVIVC for delayed release formulation drugs.
This webinar provided an overview and demonstration of Phoenix 8.2, the industry gold standard in PK/PD software.
In this 30-minute webinar, you will learn about PK Submit, a new add-on to Phoenix WinNonlin that automates the creation of PK CDISC domains during NCA analysis. It can generate both Study Data Tabulation Model (SDTM) and Standard for Exchange of Nonclinical Data (SEND) datasets. PK Submit was designed to create the entire PK regulatory … Continued
PRINCETON, NJ – July 9, 2019 – Certara has formed a new practice area called Certara Global Health (CGH) to focus its technological expertise on helping to achieve equity in health for all people worldwide.
